![]()
Sector Coverage
Biotechnology
Antisense / RNAi
Gene Therapy
Monoclonal Antibodies
Recombinant Proteins
Stem Cells
Therapeutic VaccinesDrug Delivery
Life Science Tools & Services
Drug Discovery
Genomics / Protemoics
Molecular DiagnosticsNutraceuticals
Specialty Pharmaceuticals
Recent Transactions
![]() |
Morgan Joseph
acted as co-managing underwriter in connection
with the initial public offering by Cumberland Pharmaceuticals Inc. |
![]() |
Morgan Joseph
acted as co-managing underwriter in connection
with the offering of common stock by ImmunoGen, Inc. |
![]() |
Morgan Joseph
acted as financial advisor in connection with
the registered direct offering by Spectrum Pharmaceuticals, Inc. |
![]() |
Morgan Joseph
acted as financial advisor in connection with
the registered direct offering by Spectrum Pharmaceuticals, Inc. |
![]() |
Morgan
Joseph served as a co-placement agent in
connection with the registered direct offering
by Lev Pharmaceuticals Inc. |
![]() |
Morgan
Joseph served as a co-manager in connection
with the follow-on offering of common stock
by Arena Pharmaceuticals, Inc. |
![]() |
Morgan
Joseph served as a financial advisor in connection
with the sale of the Preclinical Division
of Gene Logic Inc. to Bridge Pharmaceuticals
Inc. |
Copyright © 2010 Morgan Joseph & Co. Inc.

Contact Information
Michael
J. Innes
Managing Director
New York
212.218.3789
minnes@mjco.com
Mitchell
S. Stern
Managing Director
New York
212.218.3839
mstern@morganjoseph.com
Jill
S. Steier
Managing Director
New York
212.218.3726
jsteier@mjco.com
Michael
Holland
Vice President
Miami
305.459.1443
mholland@morganjoseph.com